KRNY vs SRPT · P/E 14, rev $324.3M vs rev $1.13B
Kearny Financial Corp (KRNY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Kearny Financial Corp (KRNY) is a banks - regional company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported KRNY revenue for 2026-06-30 was $324.3M. Net income was $36.3M. Revenue was down 0.1% from 2025-06-30 to 2026-06-30. KRNY currently screens at market cap $502.2M and trailing P/E 14.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
KRNY currently screens at market cap $502.2M and trailing P/E 14.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the KRNY and SRPT stock pages for the full models.
Not investment advice.